Back
Garmin Vs. Akero Therapeutics Industry Stock Comparison
Buy
67
GRMN
Garmin
Last Price:
149.25
Seasonality Move:
0.17%
Sell
48
AKRO
Akero Therapeutics
Last Price:
25.27
Seasonality Move:
12.31%
Buy
67
Garmin (GRMN)
is a Buy
Is Garmin a Buy, Sell or Hold?
- The current Garmin [GRMN] share price is $147.98. The Score for GRMN is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
- GRMN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
48
Akero Therapeutics (AKRO)
is a Sell
Is Akero Therapeutics a Buy, Sell or Hold?
- The current Akero Therapeutics [AKRO] share price is $24.48. The Score for AKRO is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- AKRO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $24.48
The current trend is relatively stagnant and AKRO is experiencing slight buying pressure.
GRMN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.26 | Buy |
Relative Strength Index (14 RSI): | 73.3 | Buy |
Chaikin Money Flow: | 479264 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (137.69 - 147.65) | Buy |
Bollinger Bands (100): | (118.39 - 137.33) | Buy |
AKRO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.06 | Sell |
Relative Strength Index (14 RSI): | 43.35 | Sell |
Chaikin Money Flow: | 171453 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (24.88 - 29.44) | Sell |
Bollinger Bands (100): | (17.36 - 26.04) | Buy |
GRMN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 147.08 | Buy |
20-day SMA: | 144.5 | Buy |
50-day SMA: | 133.11 | Buy |
200-day SMA: | 116.42 | Buy |
8-day EMA: | 146.98 | Buy |
20-day EMA: | 143.65 | Buy |
50-day EMA: | 136.14 | Buy |
200-day EMA: | 120.15 | Buy |
AKRO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 25.24 | Sell |
20-day SMA: | 27.54 | Sell |
50-day SMA: | 24.21 | Buy |
200-day SMA: | 31.66 | Sell |
8-day EMA: | 25.32 | Sell |
20-day EMA: | 26 | Sell |
50-day EMA: | 24.96 | Sell |
200-day EMA: | 28.74 | Sell |
Garmin Earnings Growth & GRMN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.20 per share, an increase this year of $0.08 per share, and an increase next year of $0.62 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.36 per share, a decrease next quarter of $0.16 per share, a decrease this year of $1.11 per share, and a decrease next year of $0.63 per share.
Garmin Technical Analysis
Mar 14 | Mar 15 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 22 | Mar 25 | Mar 26 | Mar 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Akero Therapeutics Technical Analysis
Mar 14 | Mar 15 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 22 | Mar 25 | Mar 26 | Mar 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |